HLS Therapeutics Eulerpool Haberleri

HLS Therapeutics Eulerpool News

HLS Therapeutics Hisse Haberleri

HLS Therapeutics, dünya çapında birçok gazeteci ve yatırımcı tarafından takip edilmektedir. En güncel HLS Therapeutics haberlerini burada bir araya getiriyoruz.

• 2 Temmuz ·

  Yahoo
  HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust
• 8 Haziran ·

  Yahoo
  HLS Therapeutics Reports Annual Meeting Results
• 5 Haziran ·

  Yahoo
  Shareholders in HLS Therapeutics (TSE:HLS) are in the red if they invested three years ago
• 28 Mayıs ·

  Yahoo
  New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment
• 9 Mayıs ·

  Yahoo
  An Intrinsic Calculation For HLS Therapeutics Inc. (TSE:HLS) Suggests It's 44% Undervalued
• 9 Mayıs ·

  Yahoo
  HLS Therapeutics Announces Q1 2024 Financial Results
• 25 Nisan ·

  Yahoo
  HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
• 9 Nisan ·

  Yahoo
  HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
• 8 Nisan ·

  Yahoo
  New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
• 17 Mart ·

  Yahoo
  Earnings Release: Here's Why Analysts Cut Their HLS Therapeutics Inc. (TSE:HLS) Price Target To CA$6.57